List of Excipients in API atovaquone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing atovaquone
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
GlaxoSmithKline LLC | MEPRON | atovaquone | 0173-0665 | BENZYL ALCOHOL | |
GlaxoSmithKline LLC | MEPRON | atovaquone | 0173-0665 | POLOXAMER 188 | |
GlaxoSmithKline LLC | MEPRON | atovaquone | 0173-0665 | SACCHARIN SODIUM | |
GlaxoSmithKline LLC | MEPRON | atovaquone | 0173-0665 | WATER | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing atovaquone
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 | BENZYL ALCOHOL |
Pharmaceutical Associates Inc | atovaquone | 0121-0888 | CITRIC ACID MONOHYDRATE |
Pharmaceutical Associates Inc | atovaquone | 0121-0888 | POLOXAMER 188 |
Pharmaceutical Associates Inc | atovaquone | 0121-0888 | PROPYLENE GLYCOL |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for atovaquone
Excipient focus: ALCOHOL
atovaquone drug variants containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
VistaPharm LLC | atovaquone | 66689-062 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: BENZYL ALCOHOL
atovaquone drug variants containing BENZYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing BENZYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
atovaquone drug variants containing CELLULOSE, MICROCRYSTALLINE
atovaquone drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
atovaquone drug variants containing CITRIC ACID MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
Northstar Rx LLC | atovaquone | 16714-900 |
Lupin Pharmaceuticals Inc | atovaquone | 68180-282 |
Glenmark Pharmaceuticals Inc USA | atovaquone | 68462-421 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing CITRIC ACID MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
Major Pharmaceuticals | atovaquone | 0904-7064 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
atovaquone drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | atovaquone and proguanil hydrochloride | 0378-4160 |
Golden State Medical Supply Inc | atovaquone and proguanil hydrochloride | 51407-869 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
atovaquone drug variants containing FERRIC OXIDE RED
atovaquone drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
atovaquone drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | atovaquone and proguanil hydrochloride | 0378-4160 |
Golden State Medical Supply Inc | atovaquone and proguanil hydrochloride | 51407-869 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
atovaquone drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | atovaquone and proguanil hydrochloride | 0378-4160 |
Golden State Medical Supply Inc | atovaquone and proguanil hydrochloride | 51407-869 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
atovaquone drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Golden State Medical Supply Inc | atovaquone | 51407-642 |
Bionpharma Inc | atovaquone | 69452-252 |
Kesin Pharma | atovaquone | 81033-104 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
atovaquone drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
atovaquone drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
atovaquone drug variants containing HYPROMELLOSE
atovaquone drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
atovaquone drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
PAI Holdings LLC | atovaquone | 0121-0898 |
Major Pharmaceuticals | atovaquone | 0904-7064 |
Camber Pharmaceuticals Inc | atovaquone | 31722-629 |
AvPAK | atovaquone | 50268-086 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
KVK-Tech Inc | atovaquone | 10702-223 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
atovaquone drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | atovaquone and proguanil hydrochloride | 0378-4160 |
Golden State Medical Supply Inc | atovaquone and proguanil hydrochloride | 51407-869 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
atovaquone drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
atovaquone drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
atovaquone drug variants containing MAGNESIUM STEARATE
atovaquone drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
atovaquone drug variants containing POLOXAMER 188
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing POLOXAMER 188
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
atovaquone drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | atovaquone and proguanil hydrochloride | 0378-4160 |
Golden State Medical Supply Inc | atovaquone and proguanil hydrochloride | 51407-869 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
atovaquone drug variants containing POLYETHYLENE GLYCOL 400
atovaquone drug variants not containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
atovaquone drug variants containing POLYETHYLENE GLYCOL 8000
atovaquone drug variants not containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
atovaquone drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | atovaquone and proguanil hydrochloride | 0378-4160 |
Golden State Medical Supply Inc | atovaquone and proguanil hydrochloride | 51407-869 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
atovaquone drug variants containing POVIDONE K30
atovaquone drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
atovaquone drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
VistaPharm LLC | atovaquone | 66689-062 |
Lupin Pharmaceuticals Inc | atovaquone | 68180-282 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
Major Pharmaceuticals | atovaquone | 0904-7064 |
>Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
atovaquone drug variants containing SACCHARIN SODIUM
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing SACCHARIN SODIUM
Excipient focus: SILICON DIOXIDE
atovaquone drug variants containing SILICON DIOXIDE
atovaquone drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
atovaquone drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Golden State Medical Supply Inc | atovaquone | 51407-642 |
Bionpharma Inc | atovaquone | 69452-252 |
Kesin Pharma | atovaquone | 81033-104 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
atovaquone drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
atovaquone drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
atovaquone drug variants containing TITANIUM DIOXIDE
atovaquone drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
atovaquone drug variants containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
VistaPharm LLC | atovaquone | 66689-062 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
atovaquone drug variants containing TRISODIUM CITRATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Northstar Rx LLC | atovaquone | 16714-900 |
Glenmark Pharmaceuticals Inc USA | atovaquone | 68462-421 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing TRISODIUM CITRATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
atovaquone drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
Major Pharmaceuticals | atovaquone | 0904-7064 |
KVK-Tech Inc | atovaquone | 10702-223 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
Lupin Pharmaceuticals Inc | atovaquone | 68180-282 |
GlaxoSmithKline LLC | atovaquone and proguanil hydrochloride | 0173-0675 |
>Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
atovaquone drug variants containing XANTHAN GUM
Company | Ingredient | NDC |
---|---|---|
Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
PAI Holdings LLC | atovaquone | 0121-0898 |
PAI Holdings LLC | atovaquone | 0121-1016 |
GlaxoSmithKline LLC | atovaquone | 0173-0665 |
>Company | >Ingredient | >NDC |
atovaquone drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.